Cargando…
Cell-Penetrating Botulinum Neurotoxin Type A With Improved Cellular Uptake and Therapeutic Index
Botulinum neurotoxin serotype A (BoNTA) is widely used for treating neuromuscular disorders. Despite of the various marketed products, BoNTA is known to have small therapeutic index ranging from 5 to 15. In the present study, we designed and characterized engineered BoNTA proteins with fusion of cel...
Autores principales: | Wei, Xuan, Li, Lu, Wu, Yiwen, Liu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874009/ https://www.ncbi.nlm.nih.gov/pubmed/35223792 http://dx.doi.org/10.3389/fbioe.2022.828427 |
Ejemplares similares
-
Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance
por: Thirunavukkarasu, Nagarajan, et al.
Publicado: (2018) -
Production and characterization of cell-penetrating recombinant botulinum neurotoxin type A
por: Wei, Xuan, et al.
Publicado: (2023) -
Influence of Colonies’ Morphological Cues on Cellular Uptake Capacity of Nanoparticles
por: Huang, Siyuan, et al.
Publicado: (2022) -
Micro Versus Macro – The Effect of Environmental Confinement on Cellular Nanoparticle Uptake
por: Damle, Viraj G., et al.
Publicado: (2020) -
Designing and Characterization of a Novel Delivery System for Improved Cellular Uptake by Brain Using Dendronised Apo-E-Derived Peptide
por: Al-azzawi, Shafq, et al.
Publicado: (2019)